Susquehanna International Group’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-93,400
| Closed | -$1.76M | – | 11231 |
|
|
2019
Q3 | $1.76M | Buy |
93,400
+42,300
| +83% | +$484K | ﹤0.01% | 4470 |
|
|
2019
Q2 | $601K | Buy |
51,100
+25,700
| +101% | +$311K | ﹤0.01% | 6891 |
|
|
2019
Q1 | $347K | Buy |
+25,400
| New | +$329K | ﹤0.01% | 6970 |
|
|
2018
Q4 | – | Sell |
-16,800
| Closed | -$280K | – | 10485 |
|
|
2018
Q3 | $280K | Sell |
16,800
-1,900
| -10% | -$34.3K | ﹤0.01% | 7615 |
|
|
2018
Q2 | $295K | Sell |
18,700
-12,500
| -40% | -$190K | ﹤0.01% | 7887 |
|
|
2018
Q1 | $396K | Buy |
+31,200
| New | +$451K | ﹤0.01% | 7110 |
|
|
2017
Q4 | – | Sell |
-83,800
| Closed | -$1.03M | – | 10229 |
|
|
2017
Q3 | $1.03M | Buy |
+83,800
| New | +$874K | ﹤0.01% | 5221 |
|
|
2017
Q2 | – | Sell |
-35,600
| Closed | -$740K | – | 10172 |
|
|
2017
Q1 | $740K | Buy |
35,600
+500
| +1% | +$11.1K | ﹤0.01% | 5753 |
|
|
2016
Q4 | $730K | Sell |
35,100
-5,700
| -14% | -$148K | ﹤0.01% | 6183 |
|
|
2016
Q3 | $1.34M | Sell |
40,800
-71,200
| -64% | -$2.17M | ﹤0.01% | 4256 |
|
|
2016
Q2 | $2.8M | Buy |
112,000
+27,000
| +32% | +$730K | ﹤0.01% | 3034 |
|
|
2016
Q1 | $2.08M | Buy |
85,000
+23,800
| +39% | +$551K | ﹤0.01% | 3692 |
|
|
2015
Q4 | $2.02M | Sell |
61,200
-7,600
| -11% | -$257K | ﹤0.01% | 4009 |
|
|
2015
Q3 | $2.25M | Buy |
68,800
+23,600
| +52% | +$1M | ﹤0.01% | 4042 |
|
|
2015
Q2 | $2.39M | Buy |
+45,200
| New | +$1.64M | ﹤0.01% | 4326 |
|
Susquehanna International Group's ALDR Position: Q4 2019 in Review
Susquehanna International Group sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 215,124 shares — an estimated $4.06M sold.
Susquehanna International Group first reported a position in ALDR in Q2 2014 and held it in 13 quarters. The position peaked at $4.06M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Susquehanna International Group reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Susquehanna International Group sold 215,124 Alder Biopharmaceuticals shares in Q4 2019, an estimated $4.06M.
- Susquehanna International Group first reported a position in Alder Biopharmaceuticals in Q2 2014 and held it in 13 quarters.
- Susquehanna International Group's Alder Biopharmaceuticals position peaked at $4.06M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.